Program to help stroke survivors manage their health

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial evaluates a transitional care program designed to assist stroke survivors in managing their risk factors to reduce the likelihood of a repeat stroke. Participants will track their medications, exercise, and health information using smart devices, while also engaging with healthcare providers and answering health-related questions. The study compares the effectiveness of the program based on the timing of enrollment, either immediately after hospital discharge or several months later, to determine the optimal approach for improving health outcomes.

Why it matters

Who can join: the full rules

Inclusion Criteria:

All Cohorts:

* Age 30 or above
* Evidence of ischemic stroke documented on CT or MRI
* Modified Rankin score of 3 or less

Early Enrollment:

* Admission for ischemic stroke at a participating site
* Enrolled during their admission for ischemic stroke or within 24 hours of discharge

Late Enrollment:

* Stroke survivors previously admitted at the participating sites' inpatient stroke unit
* Enrollment date between 1 and 6 months after discharge for inpatient admission for ischemic stroke

Exclusion Criteria:

* Participants determined to have hemorrhagic or periprocedural stroke based on hospital EMR review will be excluded.
* Participants determined to have an ischemic stroke due to dissection based on hospital EMR review will be excluded.
* Participants who lack capacity determined by the care team during their hospitalization (for the early enrollment group) or their most recent clinical encounter (for the late enrollment group) will be excluded.
* Participants with a diagnosis of dementia will be excluded.
* Participants with acute subdural hemorrhage will be excluded.
* Participants with hemorrhagic stroke due to vascular abnormality (aneurysm or AVM) or trauma will be excluded.
* Participants who cannot perform the following will be excluded:

  1. offer a consistent choice about participating in the study
  2. demonstrate that they can comprehend and recall major features of the study including: participation is voluntary, the major procedures, the primary risk, and the primary benefit.
* Participants who are discharged to Long-term Acute Care Hospitals will be excluded.
* Participants who are unable to read or communicate fluently in English will be excluded.
* Participants who do not have reliable internet access to complete telemedicine visits per self-report will be excluded.
* Participants already enrolled in another clinical study which could impact the frequency of monitoring or care that participant receives.
* Participants who do not reside in Virginia, West Virginia, Tennessee, Oklahoma, Illinois, or Michigan will be excluded.

Where it's running

• Valley Health System
  Winchester, Virginia, United States Recruiting

Study contacts

• Study coordinator: Research Coordinator
• Email: admin@syntrillo.com
• Phone: 434-202-3450

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Paired VNS: How the Brain and Pupils Respond in Stroke Patients

  This study tests real-time physiologic responses to paired VNS in adults with chronic motor impairment after ischemic stroke to help tailor dosing.

  Recruiting MGH Institute of Health Professions · Boston, Massachusetts · NCT07922200

• NeuroAiD test in mild to moderate ischemic stroke patients

  This study tests whether adding MLC901 (NeuroAiD II) to standard stroke care helps adults who recently had an ischemic stroke recover better than standard care alone.

  Recruiting Phase 4 EVD Pharmacy and Medical Company Limited · Ho Chi Minh City · NCT07828210

• Using IMPROVE to guide carotid revascularisation decisions

  This trial tests whether using the IMPROVE MRI-based score to select patients for carotid revascularisation is as good as standard care based mainly on stenosis degree, among people who have had a recent stroke or TIA due to carotid disease.

  Recruiting Maastricht University Medical Center · Arnhem, Gelderland and 9 other locations · NCT07556887

• High-intensity interval versus moderate continuous exercise for stroke-related muscle loss

  This will test whether high-intensity interval training (HIIT) or moderate-intensity continuous training (MCIT) better helps people 1–6 months after an ischemic stroke who have muscle loss regain muscle mass, strength, walking ability, and quality of life.

  Recruiting Fenerbahce University · Istanbul, Ataşehir · NCT07456956

• Test of adding a very low-dose edoxaban to standard antiplatelet therapy to prevent another stroke in adults 75 and older

  This trial tests whether adding a tiny amount of edoxaban to aspirin or clopidogrel can better prevent a second stroke in people aged 75+ who recently had an ischemic stroke.

  Recruiting Phase 3 Sunnybrook Health Sciences Centre · Toronto, Ontario · NCT07454707

• HR-MRI–Directed Tirofiban Therapy for Late-Window ICAS-LAA Stroke

  We’re testing whether tirofiban plus dual antiplatelet therapy, guided by high-resolution MRI of the brain’s blood vessels, can help people with intracranial large-artery atherosclerosis strokes that begin more than 24 hours after onset.

  Recruiting Phase 3 Weifang Medical University · Weifang, China/Shandong Province · NCT07379190

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.